GalT-KO pigs: is the cup half empty or half full?
Sachs
David H
DH
Transplantation Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. david.sachs@tbrc.mgh.harvard.edu
Yamada
Kazuhiko
K
Robson
Simon C
SC
Fishman
Jay A
JA
Shimizu
Akira
A
Colvin
Robert B
RB
Sykes
Megan
M
D000818:Animals; D030801:Animals, Genetically Modified; D003326:Coronary Circulation / Q000276:immunology; D005700:Galactosyltransferases / Q000235:genetics*; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D008833:Microcirculation; D016377:Organ Transplantation / Q000009:adverse effects / Q000639:trends; D010215:Papio; D012079:Renal Circulation / Q000276:immunology; D013552:Swine; D023001:Transplantation Tolerance / Q000276:immunology; D014183:Transplantation, Heterologous / Q000276:immunology
D005700:Galactosyltransferases; C045097:UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferase